Literature DB >> 2835648

Chronic caffeine or theophylline exposure reduces gamma-aminobutyric acid/benzodiazepine receptor site interactions.

D J Roca1, G D Schiller, D H Farb.   

Abstract

Methylxanthines, such as caffeine and theophylline, are adenosine receptor antagonists that exert dramatic effects upon the behavior of vertebrate animals by increasing attentiveness, anxiety, and convulsive activity. Benzodiazepines, such as flunitrazepam, generally exert behavioral effects that are opposite to those of methylxanthines. We report the finding that chronic exposure of embryonic brain neurons to caffeine or theophylline reduces the ability of gamma-aminobutyric acid (GABA) to potentiate the binding of [3H]flunitrazepam to the GABA/benzodiazepine receptor. This theophylline-induced "uncoupling" of GABA- and benzodiazepine-binding site allosteric interactions is blocked by chloroadenosine, an adenosine receptor agonist, indicating that the chronic effects of theophylline are mediated by a site that resembles an adenosine receptor. We speculate that adverse central nervous system effects of long-term exposure to methylxanthines such as in caffeine-containing beverages or theophylline-containing medications may be exerted by a cell-mediated modification of the GABAA receptor.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2835648

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  9 in total

Review 1.  Molecular and cellular mechanisms of GABA/benzodiazepine-receptor regulation: electrophysiological and biochemical studies.

Authors:  M Farrant; T T Gibbs; D H Farb
Journal:  Neurochem Res       Date:  1990-02       Impact factor: 3.996

2.  Enhancement by benzodiazepines of the inhibitory effect of adenosine on skeletal neuromuscular transmission.

Authors:  L C Chiou; J Y Ling; C C Chang
Journal:  Br J Pharmacol       Date:  1995-09       Impact factor: 8.739

3.  Caffeine and Cannabis Effects on Vital Neurotransmitters and Enzymes in the Brain Tissue of Juvenile Experimental Rats.

Authors:  J O Owolabi; S Y Olatunji; A J Olanrewaju
Journal:  Ann Neurosci       Date:  2017-05-12

Review 4.  The Use of Caffeine by People with Epilepsy: the Myths and the Evidence.

Authors:  Prisca R Bauer; Josemir W Sander
Journal:  Curr Neurol Neurosci Rep       Date:  2019-05-14       Impact factor: 5.081

5.  Separate and combined effects of caffeine and alprazolam on motor activity and benzodiazepine receptor binding in vivo.

Authors:  G B Kaplan; N T Tai; D J Greenblatt; R I Shader
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

6.  Experimental study of pre- and postnatal caffeine exposure and its observable effects on selected neurotransmitters and behavioural attributes at puberty : Caffeine exposure and its observable effects on selected neurotranmitters and behaviour.

Authors:  Joshua O Owolabi; Kehinde A Adefule; Philemon D Shallie; Oluseyi S Fabiyi; Sunday Y Olatunji; John Afeez Olanrewaju; Testimony P Ajibade; Samson Oyewumi; Philip O Ogunnaike
Journal:  Metab Brain Dis       Date:  2021-08-30       Impact factor: 3.584

7.  IV ATP potentiates midazolam sedation as assessed by bispectral index.

Authors:  Satoru Sakurai; Atsuo Fukunaga; Tatsuya Ichinohe; Yuzuru Kaneko
Journal:  Anesth Prog       Date:  2014

Review 8.  Caffeine: An Overview of Its Beneficial Effects in Experimental Models and Clinical Trials of Parkinson's Disease.

Authors:  Giovanni Schepici; Serena Silvestro; Placido Bramanti; Emanuela Mazzon
Journal:  Int J Mol Sci       Date:  2020-07-04       Impact factor: 5.923

9.  Evodiamine Reduces Caffeine-Induced Sleep Disturbances and Excitation in Mice.

Authors:  Yong-Hyun Ko; Kyu-Yeon Shim; Seok-Yong Lee; Choon-Gon Jang
Journal:  Biomol Ther (Seoul)       Date:  2018-09-01       Impact factor: 4.634

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.